Hayrapet Kalashyan on Muck Rack

Hayrapet Kalashyan

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hayrapet

Contact Hayrapet, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Hayrapet Kalashyan, Khurshid Khan, Thomas Jeerakathil, Ashfaq Shuaib, Maher Saqqur, Harald Becher, Cian O’Kelly, Helen Romanchuk, Andrew Wassef
| secure.jbs.elsevierhealth.com
Open in Who Shared Issue with article?

Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation

|
By Laura C. Gioia, Mahesh Kate, Leka Sivakumar, Brian Buck, Thomas Jeerakathil, Ashfaq Shuaib, Derek Emery, Dulara Hussain, Hayrapet Kalashyan, Miguel Bussiere
| stroke.ahajournals.org
Background and Purpose—Early anticoagulation after cardioembolic stroke remains controversial because of the potential for hemorrhagic transformation (HT). We tested the safety and feasibility of initiating rivaroxaban ≤14 days after cardioembolic stroke/transient ischemic attack. Methods—A prospective, open-label study of patients with atrial fibrillation treated with rivaroxaban ≤14 days of transient ischemic attack or ischemic stroke (National Institute of Health Stroke Scale <9).
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified